42 Stocks Moving in Wednesday's Pre-Market Session

Gainers

• Momenta Pharmaceuticals, Inc. MNTA shares rose 68% to $52.00 in pre-market trading after Johnson & Johnson announced plans to acquire Momenta Pharmaceuticals for $6.5 billion in cash.
• Hudson Ltd. HUD shares rose 48.2% to $7.60 in pre-market trading after the company reported proposed acquisition of all remaining equity interests in the company for $7.70 per share in cash by Dufry AG Group, Hudson’s controlling shareholder.
• 9 Meters Biopharma, Inc. NMTR rose 40% to $0.9101 in pre-market trading following the company's form 4 filing indicating an insider buy of 100,000 shares. 9 Meters Biopharma shares jumped around 17% on Tuesday after Brookline Capital initiated coverage on the company's stock with a Buy rating and announced a $5 price target.
• LightInTheBox Holding Co., Ltd. LITB rose 32% to $3.73 in pre-market trading after the company swung to a profit in the second quarter. The company said it expects Q3 sales of $95 million to $110 million.
• Blonder Tongue Laboratories, Inc. BDR shares rose 23.8% to $0.94 in pre-market trading after dropping over 4% on Tuesday. Blonder Tongue Laboratories, earlier during the month, reported results for the second quarter.
• Teligent, Inc. TLGT rose 19.3% to $2.54 in pre-market trading.
• Four Seasons Education (Cayman) Inc. FEDU rose 15.2% to $1.36 in pre-market trading. Four Seasons Education is expected to release quarterly results on August 20.
• Unum Therapeutics Inc. UMRX shares rose 10.7% to $3.00 in pre-market trading. Unum Therapeutics released Q2 results last week.
• MOGU Inc. MOGU rose 10.7% to $3.01 in pre-market trading after jumping 24% on Tuesday.
• Flux Power Holdings, Inc. FLUX rose 10.7% to $4.65 in pre-market trading after dropping 17% on Tuesday Flux Power reported pricing of $10.8 million public offering last week.
• Verona Pharma plc VRNA rose 10.4% to $9.05 in pre-market trading after the company initiated multiple dose part of Phase 2 clinical trial with pMDI formulation of ensifentrine in patients with chronic obstructive pulmonary disease.
• Accelerate Diagnostics, Inc. AXDX rose 9.8% to $16.30 in pre-market trading after the company announced the FDA issued Emergency Use Authorization for its BioCheck Covid-19 antibody testing system.
• CytomX Therapeutics, Inc. CTMX rose 8.5% to $7.79 in pre-market trading.
• OneSmart International Education Group Limited ONE rose 8.1% to $5.86 in pre-market trading. OneSmart shares jumped over 30% on Tues after reporting Q3 results.
• BioLineRx Ltd. BLRX rose 8.1% to $2.28 in pre-market trading after the company announced it has achieved its enrollment target in the phase 3 GENESIS trial for planned interim analysis.
• Eastman Kodak Company KODK rose 7.9% to $8.64 in pre-market trading after rising around 5% on Tuesday.
• Energous Corporation WATT shares rose 7.9% to $4.25 in pre-market trading after climbing 18% on Tuesday. Energous, last week, introduced EN7410M module, a new wireless charging transmitter module.
• Precipio, Inc. PRPO rose 7.3% to $2.76 in pre-market trading after declining around 21% on Tuesday. Precipio released Q2 results last week.
• Pulmatrix, Inc. PULM rose 6.4% to $1.33 in pre-market trading. Pulmatrix reported Q2 results earlier during the month.
• Target Corporation TGT rose 5.7% to $144.70 in pre-market trading after reporting upbeat quarterly results. The company also reported Q2 comparable sales grew 24.3% and digital comparable sales grew 195%.
• Golden Ocean Group Limited GOGL rose 5.2% to $4.50 in pre-market trading. On Tuesday, Golden Ocean reported a Q2 loss of $0.29 per share.
• Abraxas Petroleum Corporation AXAS rose 5% to $0.21 in pre-market trading. Abraxas Petroleum shares jumped around 16% on Tuesday after the company’s board determined to renew the strategic alternatives review announced last October.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Galapagos NV GLPG fell 26.2% to $138.82 in pre-market trading as it announced its application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis (RA) didn’t get the go-ahead from the United StatesFood and Drug Administration.
• Greenpro Capital Corp. GRNQ fell 22.4% to $1.28 in pre-market trading. Greenpro Capital shares jumped 117% on Tuesday after the company announced plans to distribute twelve million shares of common stock of D'Swiss to GRNQ's shareholders.
• Eyenovia, Inc. EYEN fell 17.6% to $3.70 in pre-market trading after the company announced a proposed common stock offering.
• Sorrento Therapeutics, Inc. SRNE fell 11.6% to $10.86 in pre-market trading as a reaction to the company firing its Chief Financial Officer Jiong Shao.
• Vipshop Holdings Limited VIPS fell 13.4% to $20.70 in pre-market trading after the company reported worse-than-expected Q2 results. The company also announced the CFO will be resigning for personal reasons.
• Adtalem Global Education Inc. ATGE fell 10.5% to $32.20 in pre-market trading after reporting Q4 results.
• Hudson Capital Inc. HUSN fell 9.3% to $0.4875 in pre-market trading after climbing 13% on Tuesday..
• NTN Buzztime, Inc. NTN shares fell 9.1% to $2.29 in pre-market trading. NTN Buzztime, last week, announced a merger deal with Brooklyn ImminoTherapeutics.
• Sabre Corp SABR fell 8.6% to $7.21 in pre-market trading after the company reported a $250 million offering at $100 per share.
• Sunworks, Inc. SUNW fell 7.8% to $0.83 in pre-market trading after jumping 27% on Tuesday. The Peck Co, last week, announced plans to buy Sunworks in a stock deal.
• Plymouth Industrial REIT, Inc. PLYM shares fell 7.7% to $12.74 in pre-market trading after the company priced offering of 7.5 million shares of common stock at $12.85 per share.
• Albireo Pharma Inc ALBO fell 7.4% to $25.00 in pre-market trading after the company announced on Tuesday its Phase 2 trial did not achieve proof-of-concept for other key NASH measures.
• Xenia Hotels & Resorts Inc XHR fell 7% to $8.09 in pre-market trading after the company filed for a mixed shelf offering.
• Jack Henry & Associates, Inc. JKHY fell 6.8% to $184.20 in pre-market trading after the company issued weak FY21 forecast.
• Predictive Oncology Inc. POAI fell 6.5% to $1.16 in pre-market trading after declining 5% on Tuesday. Predictive Oncology, last week, reported Q2 results.
• CBL & Associates Properties, Inc. CBL fell 6.5% to $0.18 in pre-market trading after dropping about 4% on Tuesday. CBL & Associates, earlier during the month, reported Q2 results.
• Gilead Sciences, Inc. GILD fell 6% to $64.97 in pre-market trading as it announced its application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis (RA) didn’t get the go-ahead from the United StatesFood and Drug Administration.
• India Globalization Capital, Inc. IGC fell 6% to $1.71 in pre-market trading after dropping 12% on Tuesday. India Globalization Capital, last week, said the FDA approved the initiation of the company's cannabinoid trial on Alzheimer's patients.
• Alcon AG ALC shares fell 6% to $57.54 in pre-market trading after reporting a Q2 loss.
• Forward Industries, Inc. FORD fell 5.7% to $1.67 in pre-market trading. Forward Industries shares jumped around 30% on Tuesday after the company announced on Monday it has acquired Kablooe Design.